A Role for Bradykinin Signaling in Chronic Vulvar Pain
Overview
Authors
Affiliations
Perspective: There is an unmet need for the development of more effective vulvodynia therapies. As we explore the mechanisms by which human vulvar fibroblasts respond to proinflammatory/propain stimuli, we move closer to understanding the origins of chronic vulvar pain and identifying new therapeutic targets, knowledge that could significantly improve patient care.
Exploring Localized Provoked Vulvodynia: Insights from Animal Model Research.
Nakhleh-Francis Y, Awad-Igbaria Y, Sakas R, Bang S, Abu-Ata S, Palzur E Int J Mol Sci. 2024; 25(8).
PMID: 38673846 PMC: 11050705. DOI: 10.3390/ijms25084261.
Bekauri T, Fischer S, Honn K, Maddipati K, Love T, Little C Pain. 2023; 165(4):820-837.
PMID: 37889581 PMC: 10949218. DOI: 10.1097/j.pain.0000000000003088.
Immune mechanisms in vulvodynia: key roles for mast cells and fibroblasts.
Tonc E, Omwanda G, Tovar K, Golden X, Chatterjea D Front Cell Infect Microbiol. 2023; 13:1215380.
PMID: 37360527 PMC: 10285386. DOI: 10.3389/fcimb.2023.1215380.
Inflammation, lipids, and pain in vulvar disease.
Falsetta M, Maddipati K, Honn K Pharmacol Ther. 2023; 248:108467.
PMID: 37285943 PMC: 10527276. DOI: 10.1016/j.pharmthera.2023.108467.
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases.
Rex D, Vaid N, Deepak K, Dagamajalu S, Keshava Prasad T Mol Biol Rep. 2022; 49(10):9915-9927.
PMID: 35596055 PMC: 9122735. DOI: 10.1007/s11033-022-07539-2.